AC Immune SA Insider Trades
NASDAQ: ACIUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $31.43K
- Sales
- 2 · $59.36K
- Shares bought / sold
- 10.00K / 20.00K
- Net activity
- Net selling $27,935
AC Immune SA insider activity
Over the last 12 months, AC Immune SA insiders reported 8 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $31,425 and sold $59,360 worth of stock, for net insider selling of $27,935. The largest seller was Pfeifer Andrea, with $59,360 in reported sales.
The most recent filing shows Buetler Monika (Director) reporting a transaction in 17,751 shares on Jun 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACIU's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ACIU insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 11, 2026 | June Carl HowardDirector | Award | 16,568 | — | Form 4 |
| Jun 11, 2026 | Zuegel MartinInterim CEO | Award | 33,136 | — | Form 4 |
| Jun 11, 2026 | AGUIAR-LUCANDER RENEEDirector | Award | 16,568 | — | Form 4 |
| Jun 11, 2026 | Twyman Roy ErvinDirector | Award | 16,568 | — | Form 4 |
| Jun 11, 2026 | Buetler MonikaDirector | Award | 17,751 | — | Form 4 |
| May 15, 2026 | Pfeifer AndreaChief Executive Officer | Sale | 10,000 | $27.93K | Form 4 |
| Apr 15, 2026 | Pfeifer AndreaChief Executive Officer | Sale | 10,000 | $31.43K | Form 4 |
| Apr 15, 2026 | Pfeifer AndreaChief Executive Officer | Buy | 10,000 | $31.43K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4